Business · 19/02/2014
FDA to Host Public Meeting on Evaluating Drug Safety in Pregnant Women
The US Food and Drug Administration (FDA) is requesting public comments on its approach to evaluating the safety of drugs and biological products during pregnancy in the post-approval setting, following a public meeting.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →